Status:
SUSPENDED
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
Lead Sponsor:
Dosentrx Ltd.
Conditions:
Oncology
Adherence, Medication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In recent decades, an increasing number of oral anticancer medications (oral oncolytics) have been approved. Oral oncolytics now make up to 30% of the oncology market, and their use is continually exp...
Detailed Description
ReX is a hand-held, mobile device intended to provide solid oral medication on patient demand according to a pre-programmed treatment protocol. ReX addresses poor patient adherence, tracks patient's r...
Eligibility Criteria
Inclusion
- Male or Female, at least 18 years of age
- Subject is able to swallow pills and during training successfully achieves 2 administrations of "demo" pills (Tic-Tac mints) by the ReX-C.
- Subject is able to read and understand the Informed Consent Form.
- Subject was diagnosed with cancer and receives oral oncology medication.
- Subject is intended to receive Afinitor OR Sutent OR Lenvima during the 2 months study period.
- Subject takes medication therapy at home.
- Subject is fluent in one of the following languages: Hebrew, English, Russian, Arabic.
Exclusion
- Subject has physical or mental disabilities which prevents their enrolment in this study, such as poor fine motor skills, impaired visual or auditory faculties, mental disorders or other impairment affecting ability to provide Informed Consent or use the ReX-C dispensing unit effectively.
- Subject failed to extract 2 Tic-Tacs with the Rex-C device during training.
- Subject is participating in another clinical study that does not permit participation in two studies simultaneously.
- Subject is at end stage or terminal illness with anticipated life expectancy of less than 3 months.
Key Trial Info
Start Date :
April 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04091711
Start Date
April 21 2020
End Date
February 1 2023
Last Update
September 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncology Unit, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel